HQL - Tekla Life Sciences Investors

NYSE - NYSE Delayed Price. Currency in USD
17.66
-0.11 (-0.62%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close17.77
Open17.83
Bid17.68 x 900
Ask17.70 x 1000
Day's Range17.64 - 17.83
52 Week Range14.57 - 18.00
Volume72,071
Avg. Volume101,493
Market Cap409.357M
Beta (5Y Monthly)1.51
PE Ratio (TTM)N/A
EPS (TTM)-3.04
Earnings DateN/A
Forward Dividend & Yield1.32 (7.43%)
Ex-Dividend DateNov 24, 2019
1y Target EstN/A
  • Business Wire

    Tekla World Healthcare Fund Paid Distribution

    On December 31, 2019, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is -$2,372,189, of which $3,964,000 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Healthcare Opportunities Fund Paid Distribution

    On December 31, 2019, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $82,927,042, of which $87,148,075 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Life Sciences Investors Paid Distribution

    On December 31, 2019, Tekla Life Sciences Investors paid a distribution of $0.33 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $108,031,990, of which $95,389,385 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Healthcare Investors Paid Distribution

    On December 31, 2019, Tekla Healthcare Investors paid a distribution of $0.41 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $219,856,218, of which $196,984,765 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Life Sciences Investors Declares Stock Distribution

    On November 15, 2019, Tekla Life Sciences Investors declared a stock distribution of $0.33 per share. The record date for the stock distribution is November 27, 2019 and the payable date is December 31, 2019. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder.